China Pharma Holdings Inc - ESG Rating & Company Profile powered by AI
The article includes a questions and answers table on China Pharma Holdings Inc. This analysis of China Pharma Holdings Inc was prepared by All Street Sevva using proprietary AI. This report of China Pharma Holdings Inc leverages data from across the internet and also from public filings by China Pharma Holdings Inc.
China Pharma Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 5.3 and governance score of 5.3.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | China Pharma Holdings Inc | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does China Pharma Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes China Pharma Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes China Pharma Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes China Pharma Holdings Inc offer flexible work?
Sign up for free to unlockDoes China Pharma Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes China Pharma Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes China Pharma Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose water use targets?
Sign up for free to unlockDoes China Pharma Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid China Pharma Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes China Pharma Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas China Pharma Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes China Pharma Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes China Pharma Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs China Pharma Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes China Pharma Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes China Pharma Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes China Pharma Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for China Pharma Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.